OYSTER POINT PHARMACEUTICALS
Oyster Point Pharma is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases. Oyster Point Pharmaโs lead product candidate, OC-01, a highly selective nicotinic acetylcholine receptor (nAChR) agonist, is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. Dry eye disease is a chronic, progressive condition that impacts more than 30 million Americans and is growing in prevalence. OC-01โs novel mechanism of action re-establishes tear film homeostasis by activating the trigeminal parasympathetic pathway to stimulate the glands and cells responsible for natural tear film production, known as the Lacrimal Functional Unit (LFU).
OYSTER POINT PHARMACEUTICALS
Industry:
Biopharma Clinical Trials Health Care Medical Pharmaceutical
Founded:
2015-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.oysterpointrx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
235.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Wordpress Plugins
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Flying L Partners
Flying L Partners investment in Series B - Oyster Point Pharmaceuticals
Vida Ventures
Vida Ventures investment in Series B - Oyster Point Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Series B - Oyster Point Pharmaceuticals
Invus
Invus investment in Series B - Oyster Point Pharmaceuticals
Versant Ventures
Versant Ventures investment in Series B - Oyster Point Pharmaceuticals
New Enterprise Associates
New Enterprise Associates investment in Series A - Oyster Point Pharmaceuticals
Versant Ventures
Versant Ventures investment in Series A - Oyster Point Pharmaceuticals
Official Site Inspections
http://www.oysterpointrx.com Semrush global rank: 3.82 M Semrush visits lastest month: 3.47 K
- Host name: edge.redirect.pizza
- IP address: 89.106.200.1
- Location: Luxembourg
- Latitude: 49.7498
- Longitude: 6.1661
- Timezone: Europe/Luxembourg